Other
Mixed Reality
Mixed Reality is an intervention with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (33.3%)
N/A2 (66.7%)
Trials by Status
completed267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
completedphase_3
Robot-assisted Partial Nephrectomy With and Without Mixed Reality (REALITATEM Study)
NCT06903260
recruitingnot_applicable
The Effectiveness of Mixed Reality as Interventional Tool for the Improvement on Quality of Life for People With Parkinson´s Disease.
NCT06459154
completednot_applicable
Mixed Reality With Hololens® Exercise Protocol
NCT03703518
Clinical Trials (3)
Showing 3 of 3 trials
NCT06903260Phase 3
Robot-assisted Partial Nephrectomy With and Without Mixed Reality (REALITATEM Study)
NCT06459154Not Applicable
The Effectiveness of Mixed Reality as Interventional Tool for the Improvement on Quality of Life for People With Parkinson´s Disease.
NCT03703518Not Applicable
Mixed Reality With Hololens® Exercise Protocol
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3